What do systematic reviews say?

Adverse events ‐ not reported · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19

All adverse events – not reported · people with chronic lymphocytic leukaemia

Serious adverse events ‐ not reported · individuals with moderate to severe disease

Serious adverse events ‐ not reported · outpatients withmild disease

Serious adverse events ‐ not reported · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19

Serious adverse events – not reported · people with a low platelet count

Grades 3 and 4 adverse events ‐ not reported · people with chronic lymphocytic leukaemia

Grades 3 and 4 adverse events ‐ not reported · individuals with moderate to severe disease

Grades 3 and 4 adverse events ‐ not reported · outpatients withmild disease

Adverse events associated with PET ‐ not reported · Individuals with Hodgkin lymphoma

Adverse events: clinically relevant non‐major bleeding / heparin‐induced thrombocytopenia ‐ not reported · adults with acute lymphoblastic leukaemia treated with asparaginase‐based chemotherapy

Serious adverse events measured by surgery or procedure‐related complications within 30 days ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures

Serious adverse events measured by surgery or procedure‐related complications within 30 days ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures

Serious adverse events measured by surgery or procedure‐related complications within 30 days ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures